McBarron Paul 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Sep 26, 2011
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Purchase
Common Stock, $0.001 par value per share
2011-09-23$0.50/sh+12,000$6,000→ 188,054 total
Footnotes (1)
- [F1]Includes 14,576 shares of restricted stock subject to forfeiture until vested.